Clinical Trials Browser

Lymphoma, Follicular × loncastuximab tesirine × 90 days × Clear all

NCT04998669 2026-02-10

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular